Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593.
Mehta, M P
Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 1998 - 3518-23 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
0732-183X
10.1200/JCO.1998.16.11.3518 doi
Aged
Carcinoma, Non-Small-Cell Lung--radiotherapy
Dose Fractionation, Radiation
Esophagitis--etiology
Female
Humans
Lung Neoplasms--radiotherapy
Male
Middle Aged
Radiotherapy--adverse effects
Treatment Outcome
Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 1998 - 3518-23 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
0732-183X
10.1200/JCO.1998.16.11.3518 doi
Aged
Carcinoma, Non-Small-Cell Lung--radiotherapy
Dose Fractionation, Radiation
Esophagitis--etiology
Female
Humans
Lung Neoplasms--radiotherapy
Male
Middle Aged
Radiotherapy--adverse effects
Treatment Outcome